StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BIO.VI$3.00-1.29%
Fair $3.00+0.0%

BIO.VI

Biogena Group Invest AG

Consumer Defensive / Packaged FoodsVienna

$3.00

-0.04 (-1.29%)

Fairly Valued+0.0%Fair Value $3.00Fund rank 27/100 · Data gapFallback financials|
SA 30/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $8000.00 · quality 46.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 50/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

30/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 3.3%, below the 5% threshold
Thesis & Journal · BIO.VILocal privado en este navegador · Biogena Group Invest AG
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$12M

P/E

42.9x

↑

EV/EBITDA

40.2x

↑

ROE

3.3%

↓

Gross Margin

N/A

•

Debt/Equity

N/A

•
52-Week Range$3
$2$3

TradingView lightweight chart

BIO.VI price, volumen y niveles de valoración

Último $3.060Periodo -33.5%
Fair value: $3.000

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+11.8%

FCF CAGR

—

FCF margin

—

FCF / Net income

—

Latest source

Provider fallback

Margin decomposition

Último año: revenue $351057.6 · net income $293326.0 · FCF —

2023-FY → 2026-FY

Gross margin

—— pts

Operating margin

51.0%+13.9% pts

Net margin

83.6%-35.2% pts

FCF margin

—— pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$351057.60$351057.60$368057.60$166057.60$251057.60
Net Income$293326.04$293326.04$330268.85$172402.40$298191.75
EBITDA$296855.03$296855.03$195625.48$176080.94$301715.85
EPS——0.080.040.07
Gross Margin———99.5%99.7%
Operating Margin51.0%51.0%53.2%2.1%37.1%
Net Margin83.6%83.6%89.7%103.8%118.8%
Cash Flow
Free Cash Flow——$-9000.00$25000.00—
Returns
ROE3.3%3.3%3.8%2.0%3.5%
Valuation
P/E42.8642.8620.3042.5838.54
EV/EBITDA40.2440.2434.2041.5638.01
P/B1.361.360.770.861.35
Growth & Yield
Revenue Growth-4.6%-4.6%121.6%-33.9%—
EPS Growth——91.6%-42.2%—
Dividend Yield1.6%1.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +50.2%

Total return

+50.2%

Start / end P/E

n/dx → n/dx

EPS bridge

0.08 → n/d

Residual

+48.5%

EPS growthn/d
Multiple reratingn/d
Dividend+1.6%
Residual / FX / buybacks / cross-term+48.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.